General
Not yet a member?
I’ve just been starting to get a sense of whether the “micro-blogging” concept of Twitter really has particular appeal, but one setting in which I believe the concept of being able to send very short (140 character) messages in real time would be really helpful is to provide immediate input from a live cancer meeting. [...]
0 CommentsThere’s a feature article in this week’s Newsweek that discusses the limitations of what we’ve achieved in the “War on Cancer” waged by Richard Nixon more than three decades ago. Unlike the vast, vast majority of cookie-cutter, feel-good stories about the miracles of science and all of the progress we’re making, this extensive article [...]
5 CommentsCongress is preparing to vote on a bill that would give the FDA the opportunity and responsibility to regulate the tobacco industry. The FDA would have the authority not to eliminate commercial tobacco, but it could eliminate added harmful ingredients while reducing tobacco levels in products. At the same time, it would have the [...]
0 CommentsToday’s NY Times included a high profile article about the difficult balance between the clinical value of some expensive cancer therapies and their financial value. I think it did a fair job of portraying both sides of the issue — that therapies like avastin, erbitux, and others are certainly priced aggressively [...]
14 Comments(Click on image to enlarge)
Tomorrow we start our fourth MITOC program, a meeting here on the Seattle waterfront that brings together a group of national experts in pulmonology, surgery, radiation oncology, and medical oncology to discuss new information and options for managing the tough real-life lung cancer cases that don’t have a [...]
This doesn’t directly relate to lung cancer, but in a prior post I described a trial of the vitamin D analog calcitriol (Asentar) with taxotere for treating advanced NSCLC. Although it has been very unclear whether there might be any future for this agent in lung cancer, I and many others were [...]
2 CommentsThis week, the American Cancer Society announced the results from a report on cancer death rates in the US. In past years, this has been a source of some good news, as the annual reports have shown the overall death rates to be declining for cancer overall since 1993, at a little [...]
3 CommentsFor those of you who haven’t been following the comments and overall discussion, my post on the lawsuit against the FDA and some key individuals who were part of the non-approval of Provenge in May generated a lot of attention from some people who are both knowledgeable and vocal about this issue. [...]
7 CommentsYes, I know readers here are interested primarily in lung cancer, but this is an interesting development in all of oncology, and really all of medicine. It’s reaching a point of ugly warfare between patient advocates and the FDA: as described here, a group called CareToLive, which includes patients and investors, have [...]
36 CommentsThe American Cancer Society has just recommended that breast MRIs be performed in addition to mammograms in women who are estimated to have a lifetime risk of developing breast cancer of 25%, primarily those women with a signfiicant family history of breast cancer. The evidence on breast MRI indicates that this technique [...]
16 Comments
GRACE Home
| Forums
| About GRACE
| 
Donate
| GRACE Website Tutorial
| Contact
| Disclaimer
Disclaimer: The information provided at GRACE is for informational purposes only. The faculty of GRACE is not providing medical advice, diagnosis or treatment and cannot replace the medical advice of your doctor or health care provider. (Full Disclaimer)
© 2007-2009 GRACE. All rights reserved.
